HAILEY FE 1 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hailey Fe 1, and what generic alternatives are available?
Hailey Fe 1 is a drug marketed by Glenmark Speclt and Glenmark Pharms Ltd and is included in two NDAs.
The generic ingredient in HAILEY FE 1 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
US Patents and Regulatory Information for HAILEY FE 1
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Glenmark Speclt | HAILEY FE 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 209031-001 | Jun 5, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Glenmark Pharms Ltd | HAILEY FE 1/20 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 206597-001 | Nov 21, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
